Maya Martinez-Davis
Corporate Officer/Principal bij GSK PLC
Actieve functies van Maya Martinez-Davis
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| GSK PLC | Corporate Officer/Principal | 01-01-2020 | - |
Loopbaan van Maya Martinez-Davis
Eerdere bekende functies van Maya Martinez-Davis
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| MIRATI THERAPEUTICS | Director/Board Member | 06-12-2018 | 23-01-2024 |
| Independent Dir/Board Member | 06-12-2018 | 23-01-2024 | |
| MERCK KGAA | Corporate Officer/Principal | 01-01-2016 | 01-08-2019 |
Opleiding van Maya Martinez-Davis
| St. Louis University | Undergraduate Degree |
| Instituto de Empresa SL | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 3 |
| Duitsland | 2 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| MERCK KGAA | Health Technology |
| GSK PLC | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
- Beurs
- Insiders
- Maya Martinez-Davis
- Ervaring
